MetLife Investment Management’s Scilex Holding SCLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.5K Hold
1,090
﹤0.01% 2873
2026
Q1
$7.26K Hold
1,090
﹤0.01% 2756
2025
Q4
$13.3K Hold
1,090
﹤0.01% 2796
2025
Q3
$21.5K Sell
1,090
-1
-0.1% -$17 ﹤0.01% 2828
2025
Q2
$6.43K Sell
1,091
-2
-0.2% -$11 ﹤0.01% 2716
2025
Q1
$9.5K Hold
1,093
﹤0.01% 2769
2024
Q4
$16.3K Hold
1,093
﹤0.01% 2795
2024
Q3
$35.4K Hold
1,093
﹤0.01% 2788
2024
Q2
$73.8K Buy
1,093
+116
+12% +$4.89K ﹤0.01% 2702
2024
Q1
$54.4K Hold
977
﹤0.01% 2706
2023
Q4
$69.8K Buy
+977
New +$50.7K ﹤0.01% 2735
2023
Q3
Sell
-977
Closed -$191K 2968
2023
Q2
$191K Hold
977
﹤0.01% 2304
2023
Q1
$281K Buy
+977
New +$271K ﹤0.01% 2009

Other funds holding SCLX

MetLife Investment Management's SCLX Position: Q2 2026 in Review

MetLife Investment Management held its Scilex Holding (SCLX) position steady in Q2 2026 at 1,090 shares worth $8.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2873.

MetLife Investment Management first reported a position in SCLX in Q1 2023 and has held it in 13 quarters since. The position peaked at $281K in Q1 2023. 73 funds tracked by Wall St. Rank hold SCLX as of Q2 2026.

  • MetLife Investment Management held 1,090 shares of Scilex Holding worth $8.5K as of Q2 2026.
  • MetLife Investment Management left its Scilex Holding share count unchanged in Q2 2026.
  • Scilex Holding made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #2873 holding.
  • MetLife Investment Management first reported a position in Scilex Holding in Q1 2023 and has held it in 13 quarters since.
  • MetLife Investment Management's Scilex Holding position peaked at $281K in Q1 2023.
  • 73 funds tracked by Wall St. Rank held Scilex Holding as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.